Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Trxade Group stock

Learn how to easily invest in Trxade Group stock.

Trxade Group Inc is a pharmaceutical retailers business based in the US. Trxade Group shares (MEDS) are listed on the NASDAQ and all prices are listed in US Dollars. Trxade Group employs 47 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Trxade Group

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – MEDS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Trxade Group stock price (NASDAQ: MEDS)

Use our graph to track the performance of MEDS stocks over time.

Trxade Group shares at a glance

Information last updated 2022-06-25.
Latest market close$1.66
52-week range$1.16 - $9.49
50-day moving average $1.61
200-day moving average $2.72
Wall St. target price$4.08
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.69

Buy Trxade Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Trxade Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Trxade Group price performance over time

Historical closes compared with the close of $1.66 from 2022-07-01

1 week (2022-06-24) 14.48%
1 month (2022-06-03) 0.12%
3 months (2022-04-01) -32.79%
6 months (2022-01-03) -36.88%
1 year (2021-07-02) -74.46%
2 years (2020-07-02) -73.23%
3 years (2019-07-02) 201.82%
5 years (2017-06-29) N/A

Is Trxade Group stock undervalued or overvalued?

Valuing Trxade Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Trxade Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Trxade Group's EBITDA

Trxade Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $515,212.

The EBITDA is a measure of a Trxade Group's overall financial performance and is widely used to measure a its profitability.

Trxade Group financials

Revenue TTM $10.1 million
Gross profit TTM $3.5 million
Return on assets TTM -45.2%
Return on equity TTM -101.54%
Profit margin -55.82%
Book value $0.35
Market capitalisation $11.9 million

TTM: trailing 12 months

Trxade Group share dividends

We're not expecting Trxade Group to pay a dividend over the next 12 months.

Have Trxade Group's shares ever split?

Trxade Group's shares were split on a 1:6 basis on 12 February 2020. So if you had owned 6 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Trxade Group shares – just the quantity. However, indirectly, the new 500% higher share price could have impacted the market appetite for Trxade Group shares which in turn could have impacted Trxade Group's share price.

Trxade Group share price volatility

Over the last 12 months, Trxade Group's shares have ranged in value from as little as $1.16 up to $9.49. A popular way to gauge a stock's volatility is its "beta".

MEDS.US volatility(beta: 1.35)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Trxade Group's is 1.3494. This would suggest that Trxade Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Trxade Group overview

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which fosters price transparency and serves approximately 11,800 members; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021.

Frequently asked questions

What percentage of Trxade Group is owned by insiders or institutions?
Currently 59.156% of Trxade Group shares are held by insiders and 6.639% by institutions.
How many people work for Trxade Group?
Latest data suggests 47 work at Trxade Group.
When does the fiscal year end for Trxade Group?
Trxade Group's fiscal year ends in December.
Where is Trxade Group based?
Trxade Group's address is: 3840 Land O? Lakes Boulevard, Land O'Lakes, FL, United States, 34639
What is Trxade Group's ISIN number?
Trxade Group's international securities identification number is: US89846A2078
What is Trxade Group's CUSIP number?
Trxade Group's Committee on Uniform Securities Identification Procedures number is: 89846A207

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site